EUVIMEDEUVIMED entdecken
Crossref

Small‐molecule positive allosteric modulation of homomeric kainate receptors GluK1 ‐3: development of screening assays and insight into GluK3 structure

Yasmin Bay iD, Raminta Venskutonytė iD, Stine M Frantsen, Thor S Thorsen, Maria Musgaard, Karla Frydenvang iD, Pierre Francotte iD, Bernard Pirotte, Philip C Biggin iD, Anders S Kristensen iD, Thomas Boesen iD, Darryl S Pickering und 2 weitere

The FEBS Journal · 2024

DOI: 10.1111/febs.17046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Yasmin Bay und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Hauptthemen laut MEDLINE: Kainic Acid Receptors, Kainic Acid, Thiazines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: The Lundbeck foundation, BioStructX, The Independent Research Fund Denmark - Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The kainate receptors GluK1‐3 (glutamate receptor ionotropic, kainate receptors 1–3) belong to the family of ionotropic glutamate receptors and are essential for fast excitatory neurotransmission in the brain, and are associated with neurological and psychiatric diseases. How these receptors can be modulated by small‐molecule agents is not well understood, especially for GluK3. We show that the positive allosteric modulator BPAM344 can be used to establish robust calcium‐sensitive fluorescence‐based assays to test agonists, antagonists, and positive allosteric modulators of GluK1‐3. The half‐maximal effective concentration (EC 50 ) of BPAM344 for potentiating the response of 100 μ m kainate was determined to be 26.3 μ m for GluK1, 75.4 μ m for GluK2, and 639 μ m for GluK3. Domoate was found to be a potent agonist for GluK1 and GluK2, with an EC 50 of 0.77 and 1.33 μ m , respectively, upon co‐application of 150 μ m BPAM344. At GluK3, domoate acts as a very weak agonist or antagonist with a half‐maximal inhibitory concentration (IC 50 ) of 14.5 μ m , in presence of 500 μ m BPAM344 and 100 μ m kainate for competition binding. Using H523A‐mutated GluK3, we determined the first dimeric structure of the ligand‐binding domain by X‐ray crystallography, allowing location of BPAM344, as well as zinc‐, sodium‐, and chloride‐ion binding sites at the dimer interface. Molecular dynamics simulations support the stability of the ion sites as well as the involvement of Asp761, Asp790, and Glu797 in the binding of zinc ions. Using electron microscopy, we show that, in presence of glutamate and BPAM344, full‐length GluK3 adopts a dimer‐of‐dimers arrangement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kainic Acid ReceptorsKainic AcidThiazinesCyclic S-OxidesZinc

Stichwörter der Autor:innen

X‐ray crystallographycalcium‐sensitive fluorescence‐based assayselectron microscopykainate receptorsmolecular dynamics simulations

Substanzen

Kainic Acid ReceptorsKainic AcidCyclic S-OxidesZincThiazinesBPAM344

Autor:innen und Institutionen

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
  • Department of Biochemistry, University of Oxford, UK.
  • Department of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Belgium.
  • Danish Research Institute of Translational Neuroscience-DANDRITE, Nordic-EMBL Partnership for Molecular Medicine, Department of Molecular Biology and Genetics, Aarhus University, Denmark.

ORCID-Profile: Yasmin Bay, Raminta Venskutonytė, Karla Frydenvang, Pierre Francotte, Philip C Biggin, Anders S Kristensen, Thomas Boesen, Michael Gajhede, Jette S Kastrup

Förderung

  • The Lundbeck foundation
  • BioStructX
  • The Independent Research Fund Denmark - Medical Sciences
  • The Alfred Benzon Foundation
  • DanScatt
  • Alfred Benzon Foundation

Zitieren

APA

Bay, Y., Venskutonytė, R., Frantsen, S. M., Thorsen, T. S., Musgaard, M., Frydenvang, K., Francotte, P., Pirotte, B., Biggin, P. C., Kristensen, A. S., Boesen, T., Pickering, D. S., Gajhede, M., & Kastrup, J. S. (2024). Small‐molecule positive allosteric modulation of homomeric kainate receptors GluK1 ‐3: development of screening assays and insight into GluK3 structure. The FEBS Journal. https://doi.org/10.1111/febs.17046

Vancouver

Bay Y, Venskutonytė R, Frantsen SM, Thorsen TS, Musgaard M, Frydenvang K, et al. Small‐molecule positive allosteric modulation of homomeric kainate receptors GluK1 ‐3: development of screening assays and insight into GluK3 structure. The FEBS Journal. 2024. doi:10.1111/febs.17046

BibTeX
@article{Bay2024,
  author = {Bay, Yasmin and Venskutonytė, Raminta and Frantsen, Stine M and Thorsen, Thor S and Musgaard, Maria and Frydenvang, Karla and Francotte, Pierre and Pirotte, Bernard and Biggin, Philip C and Kristensen, Anders S and Boesen, Thomas and Pickering, Darryl S and Gajhede, Michael and Kastrup, Jette S},
  title = {Small‐molecule positive allosteric modulation of homomeric kainate receptors GluK1 ‐3: development of screening assays and insight into GluK3 structure},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17046}
}
Kostenlos starten →